-Advertisement-
-Advertisement-
Home
Long-term survival benefit found in inhaled treprostinil treatment for pulmonary hypertension associated with IILD
Interstitial Lung Disease
Long-term survival benefit found in inhaled treprostinil treatment for pulmonary hypertension associated with IILD
A post-hoc analysis of the INCREASE trial and its open-label extension (OLE) suggests a significant long-term survival benefit associated with inhaled treprostinil treatment in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD), according to a study. The study aimed to evaluate the extended impact of inhaled treprostinil on...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Quizzes
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved